are 3 dose levels for vorinostat that are being tested.
the cancer is responding and what side effects the participant is experiencing.
not take the study drug vorinostat.
- Physical exams will be performed regularly while participants are on this study.
are eligible to continue on the study and receive vorinostat maintenance.
greater with conventional techniques or as 10mm or greater with spiral CT scan.
Determine the maximally tolerated dose (MTD) of vorinostat when combined with fixed dose, standard carboplatin/gemcitabine in patients wtih recurrent platinum-sensitive epithelial ovarian cancer.